123 related articles for article (PubMed ID: 37980215)
1. Propensity-Score Matched Analysis of Survival Outcomes of Adjuvant Therapy in Stage II-III Signet-Ring Cell Carcinoma of the Colon.
Emile SH; Horesh N; Garoufalia Z; Gefen R; Strassmann V; Wexner SD
Clin Colorectal Cancer; 2024 Mar; 23(1):35-45. PubMed ID: 37980215
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Histologic Subtype on Receipt of Adjuvant Chemotherapy and Overall Survival in Stage III Colon Cancer: a Retrospective Cohort Analysis.
Powers BD; Felder SI; Imanirad I; Dessureault S; Dineen SP
J Gastrointest Cancer; 2021 Jun; 52(2):719-727. PubMed ID: 32743731
[TBL] [Abstract][Full Text] [Related]
3. Colorectal signet-ring cell carcinoma: benefit from adjuvant chemotherapy but a poor prognostic factor.
Hugen N; Verhoeven RH; Lemmens VE; van Aart CJ; Elferink MA; Radema SA; Nagtegaal ID; de Wilt JH
Int J Cancer; 2015 Jan; 136(2):333-9. PubMed ID: 24841868
[TBL] [Abstract][Full Text] [Related]
4. Superior survival in right-sided versus left-sided colon signet ring cell carcinoma.
Zhao Z; Wang DW; Yan N; Pan S; Li ZW
Sci Rep; 2020 Oct; 10(1):17900. PubMed ID: 33087797
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of signet ring cell histology in stage I/II colon cancer-a population-based, propensity score-matched analysis.
Ackermann CJ; Guller U; Jochum W; Schmied BM; Warschkow R
Int J Colorectal Dis; 2018 Sep; 33(9):1183-1193. PubMed ID: 29881972
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy for stage II right-sided and left-sided colon cancer: analysis of SEER-medicare data.
Weiss JM; Schumacher J; Allen GO; Neuman H; Lange EO; Loconte NK; Greenberg CC; Smith MA
Ann Surg Oncol; 2014 Jun; 21(6):1781-91. PubMed ID: 24643898
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features and survival outcomes of primary signet ring cell and mucinous adenocarcinoma of colon: retrospective analysis of VACCR database.
Thota R; Fang X; Subbiah S
J Gastrointest Oncol; 2014 Feb; 5(1):18-24. PubMed ID: 24490039
[TBL] [Abstract][Full Text] [Related]
8. Should Signet Ring Cell Histology Alter the Treatment Approach for Clinical Stage I Gastric Cancer?
Turgeon MK; Gamboa AC; Rupji M; Lee RM; Switchenko JM; El-Rayes BF; Russell MC; Cardona K; Kooby DA; Staley CA; Maithel SK; Shah MM
Ann Surg Oncol; 2021 Jan; 28(1):97-105. PubMed ID: 32524459
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of Signet Ring Cell Carcinoma of the Colon and Rectum and their Distinction of Mucinous Adenocarcinoma with Signet Ring Cells. A Comparative Study.
Pozos-Ochoa LI; Lino-Silva LS; León-Takahashi AM; Salcedo-Hernández RA
Pathol Oncol Res; 2018 Jul; 24(3):609-616. PubMed ID: 28785968
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological Features and Survival of Signet-Ring Cell Carcinoma and Mucinous Adenocarcinoma of Right Colon, Left Colon, and Rectum.
Zhu L; Ling C; Xu T; Zhang J; Zhang Y; Liu Y; Fang C; Yang L; Zhuang W; Wang R; Ping J; Wang M
Pathol Oncol Res; 2021; 27():1609800. PubMed ID: 34276258
[TBL] [Abstract][Full Text] [Related]
11. Minimally invasive surgery for stage III colon adenocarcinoma is associated with less delay to initiation of adjuvant systemic therapy and improved survival.
Lee L; Wong-Chong N; Kelly JJ; Nassif GJ; Albert MR; Monson JRT
Surg Endosc; 2019 Feb; 33(2):460-470. PubMed ID: 29967992
[TBL] [Abstract][Full Text] [Related]
12. Survival outcomes for right-versus left-sided colon cancer and rectal cancer in England: A propensity-score matched population-based cohort study.
Hodges N; Mackenzie H; D'Souza N; Brown G; Miskovic D
Eur J Surg Oncol; 2022 Apr; 48(4):841-849. PubMed ID: 34688513
[TBL] [Abstract][Full Text] [Related]
13. Lymphovascular Invasion and Perineural Invasion Negatively Impact Overall Survival for Stage II Adenocarcinoma of the Colon.
Skancke M; Arnott SM; Amdur RL; Siegel RS; Obias VJ; Umapathi BA
Dis Colon Rectum; 2019 Feb; 62(2):181-188. PubMed ID: 30640833
[TBL] [Abstract][Full Text] [Related]
14. The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials.
Cascinu S; Poli D; Zaniboni A; Lonardi S; Labianca R; Sobrero A; Rosati G; Di Bartolomeo M; Scartozzi M; Zagonel V; Pella N; Banzi M; Torri V
Eur J Cancer; 2019 Apr; 111():1-7. PubMed ID: 30797014
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base.
Hyngstrom JR; Hu CY; Xing Y; You YN; Feig BW; Skibber JM; Rodriguez-Bigas MA; Cormier JN; Chang GJ
Ann Surg Oncol; 2012 Sep; 19(9):2814-21. PubMed ID: 22476818
[TBL] [Abstract][Full Text] [Related]
16. Comparison of clinicopathological and prognostic characteristics in patients with mucinous carcinoma and signet ring cell carcinoma of the stomach.
Bozkaya Y; Erdem GU; Ozdemir NY; Demirci NS; Hocazade C; Yazıcı O; Zengin N
Curr Med Res Opin; 2017 Jan; 33(1):109-116. PubMed ID: 27646639
[TBL] [Abstract][Full Text] [Related]
17. Risk of metachronous peritoneal metastases in patients with pT4a versus pT4b colon cancer: An international multicentre cohort study.
Bastiaenen VP; Aalbers AGJ; Arjona-Sánchez A; Bellato V; van der Bilt JDW; D'Hoore AD; Espinosa-Redondo E; Klaver CEL; Nagtegaal ID; van Ramshorst B; van Santvoort HC; Sica GS; Snaebjornsson P; Wasmann KATGM; de Wilt JHW; Wolthuis AM; Tanis PJ
Eur J Surg Oncol; 2021 Sep; 47(9):2405-2413. PubMed ID: 34030920
[TBL] [Abstract][Full Text] [Related]
18. Surgical outcomes and predictors of overall survival of stage I-III appendiceal adenocarcinoma: Retrospective cohort analysis of the national cancer database.
Emile SH; Horesh N; Freund MR; Silva-Alvarenga E; Garoufalia Z; Gefen R; Wexner SD
Surg Oncol; 2024 Feb; 52():102034. PubMed ID: 38211448
[TBL] [Abstract][Full Text] [Related]
19. Improving survival of stage II-III primary gastric signet ring cell carcinoma by adjuvant chemoradiotherapy.
Li Y; Zhu Z; Ma F; Xue L; Tian Y
Cancer Med; 2020 Sep; 9(18):6617-6628. PubMed ID: 32744431
[TBL] [Abstract][Full Text] [Related]
20. The value of adjuvant chemotherapy in stage II/III colorectal signet ring cell carcinoma.
Zhao Z; Yan N; Pan S; Wang DW; Li ZW
Sci Rep; 2020 Aug; 10(1):14126. PubMed ID: 32839528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
